PlainPharmaWatch

CMS Open Payments · Program Year 2024

Nuo Therapeutics

Nuo Therapeutics reported $833.09 across General Payments, Research, and Ownership to 13 physicians and teaching hospitals across 13 transactions.

See the rankings → How this is sourced
$833.09
All-tracks total
13
Transactions
13
Recipients
−$1.9K
General Payments vs PY2023

Nuo Therapeutics reported $833.09 across all CMS Open Payments tracks (General + Research + Ownership) to 13 physicians and teaching hospitals in Program Year 2024 - ranking #1853 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $833.09, averaging $64.08 per recipient.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the publisher.

CMS Sunshine Act warrant

Manufacturer nuo-therapeutics Nuo Therapeutics

$833.09 · #1853/1,925 · 0.0% industry · PY2024

  • TOT $833.09
  • RANK #1853
  • SHARE 0.0%
  • TXN 13
  • RCP 13
  • CAT 1
  • GEN $833.09
  • ΔGEN −$1.9K
  • TOP1 13.3%
  • PY 2024

Volume peers

Nearest volume peer: Precision Medical Products Inc. ($832.29)

Karl Storz Imaging, Inc.$852.50LockedBrands$852.39McKesson Medical-Surgical Mi…$837.57Nuo Therapeutics (this)$833.09Precision Medical Products I…$832.29
All-tracks payment totals near Nuo Therapeutics (CMS Open Payments PY2024)

Nuo Therapeutics sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →

Release-over-release change

General Payments changed from PY2023 to PY2024

Nuo Therapeutics's CMS-reported General Payments decreased by $1.9K (−69.3%) from PY2023 to PY2024.

How this year-over-year comparison is scoped

The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.

CMS source labels for this exact identifier: PY2022: NUO THERAPEUTICSPY2023: NUO THERAPEUTICSPY2024: Nuo Therapeutics. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$2.7KPY2024$833.09
PY2023
$2,716.32
PY2024
$833.09

What the Data Shows for Nuo Therapeutics

Nuo Therapeutics ranks #1853 out of 1,925 companies in the CMS Open Payments database for Program Year 2024, a comparatively small 0.0% slice of all industry payments reported nationwide for the year. The underlying total is $833.09 across 13 transactions to 13 physicians and teaching hospitals - $64.08 per transaction and $64.08 per recipient on average.

Of the 1 general-payment categories charted below, "Food and Beverage" is the largest at $833.09 across 13 transactions, 100.0% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).

General Payment Breakdown by Type

Across 1 types of general payments, Nuo Therapeutics's largest category was "Food and Beverage" at $833.09 - 100.0% of General Payments.

How Nuo Therapeutics divides its payments

How the reported total splits across payment categories

1. Food and Beverage$833.09
Payment Type Amount Transactions
Food and Beverage $833.09 13

Recipient Concentration in General Payments

The five largest recipient relationships account for $409.06 (49.1%) of $833.09 in this company's General Payments records across 12 recipients.

General Payments scope note

Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Nuo Therapeutics

The five named recipients with the highest reported General Payments from this company

Amy Couch$111.08Robert Duerr$98.06Jesse Parks$66.64Farlyn Charlot$66.64Kristen Winters$66.64
  1. 1

    Amy Couch

    $111.08 across 2 reported transactions

  2. 2

    Robert Duerr

    $98.06 across 1 reported transactions

  3. 3

    Jesse Parks

    $66.64 across 1 reported transactions

  4. 4

    Farlyn Charlot

    $66.64 across 1 reported transactions

  5. 5

    Kristen Winters

    $66.64 across 1 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Similarly Concentrated Companies

Companies whose General Payments are spread across recipients about as (un)evenly as Nuo Therapeutics's, measured by the same HHI concentration index above, not by payment size.

What HHI 2,500 means here

2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Nuo Therapeutics.

Hyhte Holdings Inc.

HHI 892

Siemens Medical Solutions USA, Inc.

HHI 895

Motiva USA, LLC

HHI 886

Zambon USA Ltd.

HHI 886

Companies with Similar Payment Volumes

Open a profile or compare a similar company's CMS-reported payment pattern with Nuo Therapeutics.

Showing 6 of 1,924 companies with CMS-reported payment data.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Nuo Therapeutics's data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.